Correlation Between BB Biotech and IShares MSCI

Can any of the company-specific risk be diversified away by investing in both BB Biotech and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and iShares MSCI Korea, you can compare the effects of market volatilities on BB Biotech and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and IShares MSCI.

Diversification Opportunities for BB Biotech and IShares MSCI

0.06

Correlation Coefficient

BB Biotech  IShares MSCI

Significant diversification

The 3 months correlation between BION and IShares is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and iShares MSCI Korea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI Korea and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI Korea has no effect on the direction of BB Biotech i.e., BB Biotech and IShares MSCI go up and down completely randomly.

Pair Corralation between BB Biotech and IShares MSCI

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the IShares MSCI. But the stock apears to be less risky and, when comparing its historical volatility, BB Biotech AG is 1.09 times less risky than IShares MSCI. The stock trades about -0.05 of its potential returns per unit of risk. The iShares MSCI Korea is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  4,244  in iShares MSCI Korea on October 7, 2024 and sell it today you would lose (563.00) from holding iShares MSCI Korea or give up 13.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  iShares MSCI Korea

BB Biotech AG

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

iShares MSCI Korea

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares MSCI Korea has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Etf's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the fund sophisticated investors.

Pair Trading with BB Biotech and IShares MSCI

The main advantage of trading using opposite BB Biotech and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.

The idea behind BB Biotech AG and iShares MSCI Korea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.